Search

Your search keyword '"Maurer, Tabea"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Maurer, Tabea" Remove constraint Author: "Maurer, Tabea"
45 results on '"Maurer, Tabea"'

Search Results

2. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

3. Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies

4. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.

5. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

6. Social relationships and their impact on health‐related quality of life in a long‐term breast cancer survivor cohort.

8. Cancer‐related fatigue: Towards a more targeted approach based on classification by biomarkers and psychological factors.

11. Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

12. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

13. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.

14. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

15. Randomised controlled trial testing the feasibility of an exercise and nutrition intervention for patients with ovarian cancer during and after first-line chemotherapy (BENITA-study)

17. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

18. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

19. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

21. Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

22. The FANCM :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

23. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

24. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

25. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

26. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

27. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk

28. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

29. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women

30. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

31. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

32. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

33. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

34. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

35. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

36. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

37. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

38. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

39. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

40. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

41. Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.

42. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

43. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

44. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

45. The FANCM :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

Catalog

Books, media, physical & digital resources